Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00737360 · ClinicalTrials.gov registry record · Phase 2
Phase II Study of TAS-106 to Treat Head and Neck Cancer
A Phase 2 study, sponsored by Taiho Pharmaceutical Co..
- Terminated
- Registry status
- Phase 2
- Development phase
- 27
- Enrollment target
NCT00737360: Clinical Trial Phase 2 study, sponsored by Taiho Pharmaceutical Co..
NCT00737360 is a Phase 2 study that was terminated before completion, run by Taiho Pharmaceutical Co.. The registered enrollment target is 27 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00737360, a Phase 2 study, was terminated before completion, sponsored by Taiho Pharmaceutical Co..
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether TAS-106 is effective to patients with recurrent or metastatic head and neck cancer refractory to platinum based chemotherapy.
Primary Outcome
PFS was calculated as days from the date of registration until the earliest date of documented disease progression, death, or censoring event.
Interventions
- DRUG TAS-106
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2008-08 |
| Est. Completion | 2012-02 |
| Phase | Phase 2 |
Why NCT00737360 stopped before completion
NCT00737360 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 1 intervention - of which TAS-106 is the first listed.
NCT00737360 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00737360 about?
NCT00737360 is a clinical study titled "Phase II Study of TAS-106 to Treat Head and Neck Cancer". The purpose of this study is to determine whether TAS-106 is effective to patients with recurrent or metastatic head and neck cancer refractory to platinum based chemotherapy.
What is the current status of trial NCT00737360?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2008-08. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00737360?
The interventions under investigation include: TAS-106 (DRUG).
Who is sponsoring clinical trial NCT00737360?
This trial is sponsored by Taiho Pharmaceutical Co., which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00737360's enrollment target sits among peer trials
27 1697th of 2000 higher than 293 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia